Quironsalud Madrid
| Turchia | Austria | Spagna | |
| Tomoterapia | da $12,000 | da $30,000 | da $35,000 |
| Sistema robotico Da Vinci | da $9,500 | da $22,000 | da $17,000 |
| Rimozione di polipi gastrici | da $990 | da $5,000 | da $3,000 |
| Resezione rettale | da $10,250 | da $21,000 | da $16,000 |
| Immunoterapia con Keytruda (Pembrolizumab) | da $3,300 | da $15,000 | da $15,000 |
Oltre 12.000 interventi di chirurgia laparoscopica eseguiti – Il Dr. Ballesta Lopez ha pionierato tecniche mini-invasive per il cancro rettale presso il Centro Médico Teknon.
La dottoressa è un chirurgo oncologico specializzato in carcinosi peritoneale e fa parte del Gruppo Chirurgico di Carcinosi dell'Istituto Oncologico Teknon dal 2019. Ha completato la sua specializzazione al Washington Hospital Center sotto la guida del Prof. Paul Sugarbaker e possiede la certificazione dell'American Board of Surgery.<\/p>
È membro di diverse società prestigiose, tra cui l'American College of Surgeons e la Society of Surgical Oncology. I suoi ruoli accademici hanno incluso il Direttore della Ricerca presso l'Inova Fairfax Hospital e posizioni di Professore Associato presso la Virginia Commonwealth University e la Georgetown University.<\/p>
Il medico ha una vasta esperienza nel campo dell'oncologia peritoneale, attualmente lavora presso il Dipartimento di Carcinomatosi Peritoneale al Centro Médico Teknon in Spagna dal 2020 e presso il Dipartimento di Oncologia Peritoneale al Consorci Sanitari Integral dal 2010. In precedenza, il medico ha lavorato in chirurgia laparoscopica e robotica avanzata, nonché in chirurgia epatobiliare e pancreatica in vari ospedali prestigiosi in Spagna e Italia.<\/p>
Come esperto riconosciuto, il medico interviene frequentemente a congressi nazionali e internazionali sul trattamento chirurgico dei tumori addominali e pelvici avanzati e ha contribuito in modo significativo alla letteratura scientifica e agli studi clinici in chirurgia oncologica.<\/p>
Il medico è membro di diverse società chirurgiche e oncologiche stimate, tra cui GECOP, SEOQ, AEC, ESSO e PSOGI.<\/p>
Rectal cancer treatment in Spain utilizes multidisciplinary protocols including advanced robotic surgery, immunotherapy, and neoadjuvant chemoradiation. JCI-accredited centers in Barcelona and Madrid provide specialized techniques like transanal total mesorectal excision (TaTME) to improve tumor removal precision while preserving organ function.
Bookimed Expert Insight: Spain is a global leader in surgical innovation. Dr. Antonio de Lacy Fortuny at Hospital Quiron Barcelona pioneered the TaTME technique. Specialized clinics like Centro Médico Teknon also combine 45+ years of surgical expertise with American Board-certified oncologists. This integration of global standards and pioneering local methods allows for high success rates in complex rectal resections.
Patient Consensus: Patients note that private care significantly reduces wait times compared to public options. They emphasize that while managing a temporary ileostomy is challenging, the surgical outcomes generally allow for a return to normal life.
Permanent colostomy is usually not required for rectal cancer treatment in Spain. Most patients receive sphincter-sparing surgeries like low anterior resection. Spanish oncology centers report permanent stoma rates under 5% at specialized facilities. Surgeons use temporary stomas to allow bowel healing for 3 to 12 months.
Bookimed Expert Insight: Spain is a global leader in rectal surgery innovation. Dr. Antonio de Lacy Fortuny at Hospital Quiron Barcelona pioneered the transanal total mesorectal excision (TaTME). This technique allows surgeons to remove tumors very close to the anus while avoiding permanent bags. Clinics like Centro Médico Teknon manage over 10,000 patients annually. They often combine chemotherapy with minimally invasive robotic surgery to maximize the likelihood of restoration.
Patient Consensus: Patients emphasize monitoring tumor shrinkage through MRI to determine if a reversal is possible. Many note that preparing for a 6 to 12-month wait for reversal helps manage expectations during recovery.
Spain reports a 5-year survival rate of 62.5% to 65% for colorectal cancers. Early-stage rectal cancer survival reaches 90% in top Spanish oncology centers. Advanced Stage III cases maintain a 62% survival rate. High-volume hospitals use robotic-assisted surgery to improve these outcomes.
Bookimed Expert Insight: Data from major Spanish centers highlights the impact of surgical volume on success. Dr. Antonio de Lacy Fortuny at Hospital Quiron Barcelona has performed over 15,000 procedures. This high concentration of expertise allows Spanish clinics to pioneer techniques like transanal total mesorectal excision. Choosing a high-volume surgeon who performs 1,000+ minimally invasive surgeries annually significantly supports long-term survival prospects.
Patient Consensus: Patients emphasize that Spain's multidisciplinary tumor boards provide rapid access to chemotherapy and radiation. Many note that prioritizing pelvic floor physical therapy immediately after surgery is essential for long-term quality of life.
Barcelona and Madrid are the primary hubs for specialized rectal cancer care in Spain. Clinics like Centro Médico Teknon and Hospital Quiron Barcelona offer advanced therapies. These centers utilize JCI-accredited facilities and robotic-assisted techniques like the Da Vinci system to improve surgical precision.
Bookimed Expert Insight: Barcelona centers demonstrate exceptional surgical volume that correlates with expertise. Dr. Antonio de Lacy Fortuny at Hospital Quiron Barcelona performs over 1,000 minimally invasive procedures annually. This high frequency helps surgeons master complex techniques like Transanal Total Mesorectal Excision (TaTME).
Patient Consensus: Patients highlight that private health chains provide seamless English-speaking coordination. Many note that these centers streamline the international process by bundling medical care with administrative support.
Organ preservation trials in Spain allow some patients to avoid surgery or radiation through targeted immunotherapy or intensive chemotherapy. Strategies like watch and wait are available for tumors that disappear completely after initial treatment. Eligibility often requires specific genetic markers like mismatch repair deficiency (dMMR).
Bookimed Expert Insight: Quironsalud Madrid provides a unique pathway for patients to receive treatment for free by participating in active clinical trials. This is a significant advantage in Spain, as high-volume centers like Quironsalud Barcelona also collaborate with leading American institutes for advanced oncology research. Patients should prioritize hospitals with Joint Commission International (JCI) accreditation to ensure trial protocols follow the highest safety standards.
Patient Consensus: Patients note it is important to get dMMR testing early to unlock non-surgical options. They emphasize that while avoiding radiation improves quality of life, you must commit to frequent, rigorous MRI scans.
Spanish oncology centers use advanced technologies like the Da Vinci Xi robotic system and Transanal Total Mesorectal Excision to maximize safety. These tools enable precise tumor removal while preserving vital nerves. Surgeons also utilize fluorescence imaging to ensure healthy blood flow during complex rectal reconstructions.
Bookimed Expert Insight: Spanish centers like Centro Médico Teknon and Hospital Quiron Barcelona offer a high volume of laparoscopic and robotic procedures. Teknon alone has performed over 12,000 laparoscopic surgeries. This high patient volume often leads to better preservation of autonomic nerves. Our data shows doctors like Dr. Carlos Ballesta Lopez have over 45 years of experience in these specialized techniques.
Patient Consensus: Patients note that choosing Spanish surgeons for complex low rectal tumors improves their chances of avoiding permanent colostomy bags. They also emphasize that international departments in Barcelona and Madrid help bridge communication gaps during specialized robotic treatments.